{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:14:46Z","timestamp":1761167686919,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone &amp; IGF Research"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.ghir.2010.10.003","type":"journal-article","created":{"date-parts":[[2010,11,13]],"date-time":"2010-11-13T04:31:59Z","timestamp":1289622719000},"page":"432-437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Interactions between oral contraceptive status and GSTM1 and GSTT1 deletions on insulin-like growth factor-1 (IGF-1) plasma levels in young healthy women"],"prefix":"10.1016","volume":"20","author":[{"given":"M.C.K.","family":"Henningson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hietala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"B\u00e5geman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Jernstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2010.10.003_bb0005","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1152\/physrev.1996.76.4.1005","article-title":"Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors","volume":"76","author":"Stewart","year":"1996","journal-title":"Physiol. Rev."},{"article-title":"Biochemical Control of Breast Development","year":"2000","author":"Dickson","key":"10.1016\/j.ghir.2010.10.003_bb0010"},{"key":"10.1016\/j.ghir.2010.10.003_bb0015","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(97)10384-1","article-title":"Circulating concentrations of insulin-like growth factor-I and risk of breast cancer","volume":"351","author":"Hankinson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2010.10.003_bb0020","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1677\/erc.1.01149","article-title":"Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II","volume":"13","author":"Schernhammer","year":"2006","journal-title":"Endocr Relat Cancer."},{"key":"10.1016\/j.ghir.2010.10.003_bb0025","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0140-6736(04)16044-3","article-title":"Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis","volume":"363","author":"Renehan","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2010.10.003_bb0030","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1470-2045(10)70095-4","article-title":"Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies","volume":"11","author":"Key","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ghir.2010.10.003_bb0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000180558","article-title":"Somatomedins and steroids","volume":"24","author":"Caufriez","year":"1986","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2010.10.003_bb0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000292493","article-title":"Suppression of plasma insulin-like growth factor-1 levels in healthy, nulliparous, young women using low dose oral contraceptives","volume":"38","author":"Jernstr\u00f6m","year":"1994","journal-title":"Gynecol Obstet Invest."},{"key":"10.1016\/j.ghir.2010.10.003_bb0045","first-page":"377","article-title":"Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women","volume":"10","author":"Jernstr\u00f6m","year":"2001","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ghir.2010.10.003_bb0050","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/sj.bjc.6602389","volume":"92","author":"Jernstr\u00f6m","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ghir.2010.10.003_bb0055","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/mgme.2000.3130","article-title":"Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk","volume":"72","author":"Jernstr\u00f6m","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ghir.2010.10.003_bb0060","first-page":"733","article-title":"Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility","volume":"6","author":"Rebbeck","year":"1997","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ghir.2010.10.003_bb0065","first-page":"1239","article-title":"Metabolic gene polymorphism frequencies in control populations","volume":"10","author":"Garte","year":"2001","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ghir.2010.10.003_bb0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00204-008-0334-6","article-title":"Modulation of the GSTT1 activity by the GSTM1 phenotype in a sample of Italian farm-workers","volume":"83","author":"Fuciarelli","year":"2009","journal-title":"Arch. Toxicol."},{"issue":"Pt 3","key":"10.1016\/j.ghir.2010.10.003_bb0075","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1042\/bj3040843","article-title":"Variability of glutathione S-transferase isoenzyme patterns in matched normal and cancer human breast tissue","volume":"304","author":"Kelley","year":"1994","journal-title":"Biochem. J."},{"key":"10.1016\/j.ghir.2010.10.003_bb0080","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/carcin\/19.3.433","article-title":"Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons","volume":"19","author":"Sundberg","year":"1998","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ghir.2010.10.003_bb0085","first-page":"843","article-title":"A systematic review of genetic polymorphisms and breast cancer risk","volume":"8","author":"Dunning","year":"1999","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ghir.2010.10.003_bb0090","first-page":"229","article-title":"Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer","volume":"10","author":"Mitrunen","year":"2001","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ghir.2010.10.003_bb0095","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1158\/1055-9965.EPI-08-0917","article-title":"Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk","volume":"18","author":"Reding","year":"2009","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ghir.2010.10.003_bb0100","first-page":"567","article-title":"Glutathione S-transferases M1, T1, and P1 and breast cancer","volume":"9","author":"Millikan","year":"2000","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ghir.2010.10.003_bb0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0304-3835(02)00046-0","article-title":"GSTT1 null genotype increases risk of premenopausal breast cancer","volume":"181","author":"Matheson","year":"2002","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ghir.2010.10.003_bb0110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10238-008-0159-x","article-title":"Genetic polymorphisms in oestrogen metabolic pathway and breast cancer: a positive association with combined CYP\/GST genotypes","volume":"8","author":"Torresan","year":"2008","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.ghir.2010.10.003_bb0115","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1158\/1055-9965.1473.13.9","article-title":"Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis","volume":"13","author":"Vogl","year":"2004","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ghir.2010.10.003_bb0120","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/jnci\/90.7.512","article-title":"Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer","volume":"90","author":"Helzlsouer","year":"1998","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.ghir.2010.10.003_bb0125","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/carcin\/bgm141","article-title":"Interactions among GSTM1, GSTT1 and GSTP1 polymorphisms, cruciferous vegetable intake and breast cancer risk","volume":"28","author":"Steck","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ghir.2010.10.003_bb0130","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00001648-199709000-00014","article-title":"Age when maximum height is reached as a risk factor for breast cancer among young U.S. women","volume":"8","author":"Li","year":"1997","journal-title":"Epidemiology"},{"key":"10.1016\/j.ghir.2010.10.003_bb0135","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10689-007-9141-0","article-title":"Absence of the common IGF1 19 CA-repeat allele is more common among BRCA1 mutation carriers than among non-carriers from BRCA1 families","volume":"6","author":"Henningson","year":"2007","journal-title":"Fam Cancer."},{"key":"10.1016\/j.ghir.2010.10.003_bb0140","first-page":"620","article-title":"Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand","volume":"124","author":"Bang","year":"1991","journal-title":"Acta Endocrinol Copenh"},{"key":"10.1016\/j.ghir.2010.10.003_bb0145","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53297 women with breast cancer and 100239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer","volume":"347","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2010.10.003_bb0150","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.ejca.2005.03.035","article-title":"Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing","volume":"41","author":"Jernstr\u00f6m","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ghir.2010.10.003_bb0155","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.39289.649410.55","article-title":"Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study","volume":"335","author":"Hannaford","year":"2007","journal-title":"BMJ."},{"key":"10.1016\/j.ghir.2010.10.003_bb0160","first-page":"567","article-title":"Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus","volume":"4","author":"Colditz","year":"1995","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ghir.2010.10.003_bb0165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2265.1994.tb03788.x","article-title":"The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients","volume":"41","author":"Juul","year":"1994","journal-title":"Clin Endocrinol Oxf"},{"key":"10.1016\/j.ghir.2010.10.003_bb0170","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3816\/CBC.2008.n.038","article-title":"Examining breast cancer growth and lifestyle risk factors: early life, childhood, and adolescence","volume":"8","author":"Ruder","year":"2008","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.ghir.2010.10.003_bb0175","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/ije\/29.2.208","article-title":"Anthropometric variables in relation to risk of breast cancer in middle-aged women","volume":"29","author":"Li","year":"2000","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.ghir.2010.10.003_bb0180","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/1097-0142(19940801)74:3+<1090::AID-CNCR2820741518>3.0.CO;2-X","article-title":"Anthropometry and breast cancer. Body size--a moving target","volume":"74","author":"Ballard-Barbash","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ghir.2010.10.003_bb0185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00008469-200102000-00003","article-title":"Review of anthropometric factors and breast cancer risk","volume":"10","author":"Friedenreich","year":"2001","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.ghir.2010.10.003_bb0190","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","article-title":"Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium","volume":"343","author":"Ford","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2010.10.003_bb0195","first-page":"265","article-title":"Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium","volume":"56","author":"Easton","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ghir.2010.10.003_bb0200","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium","volume":"62","author":"Ford","year":"1998","journal-title":"Am. J. Hum. Genet."}],"container-title":["Growth Hormone &amp; IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109663741000122X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109663741000122X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:46:31Z","timestamp":1761086791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109663741000122X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S109663741000122X"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2010.10.003","relation":{},"ISSN":["1096-6374"],"issn-type":[{"type":"print","value":"1096-6374"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interactions between oral contraceptive status and GSTM1 and GSTT1 deletions on insulin-like growth factor-1 (IGF-1) plasma levels in young healthy women","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2010.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Growth Hormone Research Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}